<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In many of <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> diseases such as familial <z:hpo ids='HP_0007354'>amyotrophic lateral sclerosis</z:hpo> (ALS) with Cu/Zn <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD1) mutation, a missense point mutation may induce the disease by its gain of adverse property </plain></SENT>
<SENT sid="1" pm="."><plain>Similar 'gain of toxic function' of mutant protein is predicted to cause cell <z:hpo ids='HP_0011420'>death</z:hpo> in other <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo> such as familial <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo>, <z:e sem="disease" ids="C0162534" disease_type="Disease or Syndrome" abbrv="">prion disease</z:e>, polyglutamine diseases and <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> these <z:e sem="disease" ids="C0277558" disease_type="Disease or Syndrome" abbrv="">familial diseases</z:e>, one rational approach to therapy is to develop a method to specifically eliminate the aberrant protein </plain></SENT>
<SENT sid="3" pm="."><plain>Duplex of 21-nt <z:chebi fb="40" ids="33697">RNA</z:chebi>, known as siRNA, has recently emerged as a powerful tool to silence gene </plain></SENT>
<SENT sid="4" pm="."><plain>Mutant-allele specific gene silencing with siRNA was showed in familial ALS and <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph diseases</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>We made the transgenic (Tg) mouse of modified small interfering <z:chebi fb="40" ids="33697">RNA</z:chebi> (siRNA) </plain></SENT>
<SENT sid="6" pm="."><plain>By crossing this anti-SOD1 siRNA Tg mouse with a SOD1(G93A) Tg mouse as a model for ALS, siRNA halted the development of disease by inhibiting mutant G93A SOD1 </plain></SENT>
<SENT sid="7" pm="."><plain>Our results support the feasibility of utilizing siRNA-based gene therapy of <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo> of <z:hpo ids='HP_0000006'>autosomal dominant inheritance</z:hpo> </plain></SENT>
</text></document>